Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
92.5M
-
Shares change
-
+1.08M
-
Total reported value, excl. options
-
$1.71B
-
Value change
-
+$15.9M
-
Put/Call ratio
-
0.33
-
Number of buys
-
92
-
Number of sells
-
-73
-
Price
-
$18.47
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q3 2024
221 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q3 2024.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.5M shares
of 107M outstanding shares and own 86.31% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (17.7M shares), WELLINGTON MANAGEMENT GROUP LLP (11.2M shares), BlackRock, Inc. (6.37M shares), VANGUARD GROUP INC (5.54M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (4.49M shares), MAVERICK CAPITAL LTD (4.12M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.21M shares), STATE STREET CORP (3.1M shares), CITADEL ADVISORS LLC (2.15M shares), and JANUS HENDERSON GROUP PLC (1.9M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.